Featured
Health Topics
-
Chemicals and Drugs47
See more
- Amino Acids, Peptides, and Proteins 21
- Biological Factors 2
- Carbohydrates 1
- Chemical Actions and Uses 7
- Complex Mixtures 1
- Enzymes and Coenzymes 2
- Heterocyclic Compounds 19
- Hormones, Hormone Substitutes, and Hormone Antagonists 3
- Inorganic Chemicals 1
- Lipids 3
- Macromolecular Substances 1
- Nucleic Acids, Nucleotides, and Nucleosides 4
- Organic Chemicals 24
- Pharmaceutical Preparations 1
- Polycyclic Compounds 10
-
Diseases80
See more
- Bacterial Infections and Mycoses 3
- Cardiovascular Diseases 5
- Chemically-Induced Disorders 1
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities 17
- Digestive System Diseases 7
- Endocrine System Diseases 5
- Eye Diseases 2
- Female Urogenital Diseases and Pregnancy Complications 13
- Hemic and Lymphatic Diseases 25
- Immune System Diseases 11
- Male Urogenital Diseases 14
- Musculoskeletal Diseases 2
- Neoplasms 22
- Nervous System Diseases 13
- Nutritional and Metabolic Diseases 8
- Occupational Diseases 1
- Pathological Conditions, Signs and Symptoms 25
- Respiratory Tract Diseases 5
- Virus Diseases 3
- Wounds and Injuries 7
- Phenomena and Processes1 See more
- Psychiatry and Psychology9 See more
Search Clinical Trials
Terminated
Oral Magnesium Pidolate, Hemoglobin SC Disease, MG Pidolate (External Link)
This is a placebo-controlled study which means that the effectiveness of the magnesium medication (the chemical form of which is known as Mg pidolate) will be compared to placebo. A …
Baylor Role:
Lead Sponsor
Terminated
Stem Cell Transplantation for Patients With Graft Failure Following an Allogeneic Transplant, Using Identical or Near Identical Donors and Less Toxic Conditioning With CAMPATH 1H (External Link)
Study participants will receive the following treatment: Day -5 to -2...Fludarabine 30mg/m2* and CAMPATH** 1H 10mg IV Day -1.........Day of rest Day 0..........Stem cell transplant (infusion) Where possible, patients will …
Baylor Role:
Lead Sponsor
Terminated
Bone Marrow Transplant From Donor Using Less Toxic Conditioning for Patient With High Risk Hemoglobinopathies (External Link)
To do the stem cell transplant, we must first kill most of the cells in the bone marrow that make the sickle hemoglobin or abnormal blood cells of severe beta …
Baylor Role:
Lead Sponsor
Terminated
Bone Marrow Transplant From Related Donor for Patients With High Risk Hemoglobinopathies (External Link)
To do the bone marrow transplant, we must first kill the cells in the bone marrow that make the abnormal red blood cells that are found in patients with severe …
Baylor Role:
Lead Sponsor
Terminated
Stem Cell Transplant for Hematologic Diseases (External Link)
Before treatment begins, stem cells will be collected from the donor's blood or bone marrow. The stem cells will be collected and frozen before we start to give the patient …
Baylor Role:
Lead Sponsor
Terminated
Giving Gene Marked EBV Specific T-Cells to Patients Receiving a BMT for Relapsed EBV-Positive Hodgkin Disease (External Link)
We will take 60-70 ml (12 teaspoonfuls) of blood from the subject. We will first make a B cell line called a lymphoblastoid cell line or LCL by infecting the …
Baylor Role:
Lead Sponsor